6. July 2017
Current warnings July 2017
Since the beginning of July 2017, we have tested a number of substances of particular health concern. Many ecstasy tablets, some of which contained very high doses (up to 331 mg MDMA), were handed in for analysis. The anthelmintic levamisole was identified in many of the samples submitted for analysis as cocaine. The majority of the samples submitted for analysis as speed also contained caffeine in varying proportions. In MDMA samples, the new psychoactive substances
N-Ethylpentylone, Clephedrone (4-CMC) resp. 4-Chloroethcathinone (4-CEC) proven.